Adia Nutrition, (OTCQB: ADIA) a leader in advanced regenerative health solutions, today announced a major milestone in its ...

Blood-pressure reduction is the only proven treatment to prevent stroke. Whether a single pill that combines three ...

Tarantulas may have the reasoning to recall how to navigate places they’ve already been, a new study published in Ecology and ...

Research reveals how venture capital gender bias distorts funding decisions, underfunds strong teams, and weakens returns for ...

Touch is more than a feeling. New research shows that gentle touch can shape memory, emotions, and relationships over time.

Lonvo-z is an in vivo CRISPR gene editing candidate that is designed to inactivate the kallikrein B1 gene, thereby permanently lowering kallikrein and bradykinin levels.

In this series discover how Just Walk Out technology is eliminating checkout lines and enabling 24/7 access across multiple ...

Childhood vaccines may be unsafe because few if any have been tested in placebo-controlled trials before being approved. But ...

Human aging is not what natural selection failed to prevent. It is what happens when selection simply has nothing left to act ...

Orphan drug designation from the European Commission underscores Solid’s commitment to advance SGT-003 through a global ...

Sanofi and Regeneron's Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria Approval for children aged two to 11 years with ...

Introduction Suicidal ideation is common in young people and increases the risk of suicide. Effective interventions that are relevant and accessible to young people, so-called digital natives, are ...